U.S. Midline Catheter Market Revenue & Forecast Analysis, 2026-2035

The U.S. Centers for Disease Control and Prevention (CDC) reports that central line-associated bloodstream infections (CLABSIs) are among the most prevalent and severe healthcare-related infections in the United States, impacting thousands of patients each year and leading to greater use of safer vascular access options like midline catheters for medium-term intravenous therapy with a lower risk of infection than central venous lines.

The U.S. Midline Catheter Market has experienced consistent growth in the last ten years, fueled by the rising demand for safer vascular access options, increasing hospitalizations, and the expanding use of intermediate-duration intravenous therapy solutions. The market has also gained from the increased emphasis on decreasing central line-associated bloodstream infections (CLABSIs) and enhancing patient safety results in acute care environments. The rising utilization of ultrasound-assisted insertion methods and uniform vascular access guidelines has enhanced implementation throughout hospitals, emergency rooms, and specialized care units. For instance, in 2024, Becton, Dickinson and Company (BD) broadened its vascular access offerings by introducing advanced midline catheter and ultrasound-guided placement solutions, helping clinicians improve insertion precision and minimise catheter-related complications.

The U.S. Midline Catheter Market is projected to witness strong growth throughout the forecast period, bolstered by the increasing incidence of chronic conditions like cancer, diabetes, and infectious diseases that necessitate extended intravenous treatment. The growth of home healthcare and outpatient infusion services is speeding up adoption, as midline catheters offer a safer and more affordable option compared to central venous catheters for treatments of intermediate duration. For instance, by 2035, the use of sophisticated midline catheter systems is anticipated to rise markedly in U.S. healthcare settings, fueled by ongoing enhancements in catheter materials, antimicrobial coatings, and ultrasound-guided insertion technologies, alongside the increasing transition toward decentralised and home-based care provision.

U.S. Midline Catheter Market Overview

Base Year Market Size (2025): USD 1,168.43 Million

CAGR: 5.3%

Forecast Year Market Size (2035): USD 1,946.06 Million

Major Players:

• Becton, Dickinson and Company (BD)

• Teleflex Incorporated

• B. Braun Medical Inc.

• AngioDynamics, Inc.

• Smiths Medical (ICU Medical)

U.S. Midline Catheter Market Trends

The U.S. Midline Catheter Market is undergoing consistent change, fueled by the growing demand for safer and mid-duration vascular access options, heightened hospital attention on infection control, and a rising use of ultrasound-assisted insertion methods. Hospitals and infusion centers are progressively opting for midline catheters instead of short peripheral IVs and central venous catheters, particularly for patients needing intravenous therapy for 1–4 weeks.

• A significant trend is the increasing use of ultrasound-guided vascular access placement, which is boosting first-attempt success rates, minimizing complications, and improving overall patient outcomes. For example, extensive U.S. hospital networks are progressively training specialized vascular access teams to standardize the placement of midline catheters and reduce catheter-related bloodstream infections (CRBSIs).

• Another significant trend is the move towards antimicrobial and advanced biomaterial catheters aimed at decreasing infection risk and enhancing dwell time.

• Moreover, the market is experiencing significant growth in home healthcare and outpatient infusion services, with midline catheters being utilized more frequently for antibiotic treatment, hydration, and management of chronic conditions away from hospitals. This change is being propelled by hospitals' need to reduce costs and the increasing demand for decentralized care delivery models throughout the United States.

Overall, progress in technology, the focus on infection control, and the growth of non-hospital care environments are projected further to influence the development of the U.S. Midline Catheter Market.

U.S. Midline Catheters Market Analysis

By Design Type

Single lumen design dominates the U.S. midline catheter market due to its simplicity, lower complication risk, and wider clinical preference for single-therapy intravenous access

Based on design type, the U.S. Midline Catheter Market is categorized into single lumen and double lumen catheters. The single lumen segment holds the largest market share of 69.24% in 2025.

By Material Type

Polyurethane dominates the U.S. midline catheter market due to its superior strength, flexibility, and suitability for intermediate-term vascular access

Based on material type, the U.S. Midline Catheter Market is categorized into polyurethane and silicone. The polyurethane segment holds the largest market share in 2025.

By Application

IV antibiotics dominate the U.S. midline catheter market due to high infection burden, frequent hospital admissions, and widespread need for intermediate-duration intravenous therapy

Based on application, the U.S. Midline Catheter Market is categorized into IV antibiotics, hydration and electrolyte therapy, difficult venous access patients, and post-acute or home IV therapy. The IV antibiotics segment holds the largest market share in 2025.

By End-use

Hospitals dominate the U.S. midline catheter market due to high patient inflow, intensive IV therapy demand, and strong adoption of infection-prevention vascular access practices.

Based on end-use, the U.S. Midline Catheter Market is categorized into hospitals, ambulatory surgical centers (ASCs), specialty clinics, and others. The hospitals segment holds the largest market share in 2025.